The consultancy was officially launched in 2005 at PMEA by co-founders Claire Eldridge and Neil Crump. Since its launch, the consultancy has worked with over 100 companies in the healthcare and pharmaceutical industries, including on clinical trial recruitment, patient involvement, product launches and more.
“It has been a privilege to work with our clients to help realise the potential of their interventions, to ensure patient access to innovation and to promote collaboration across the industry,” said Eldridge.

“Pharma and healthcare have never been so vital to the world and we are more driven than ever by our purpose to change patient lives,” she added.
“Over the next 15 years, healthcare and communications are going to change dramatically, they will be almost unrecognisable,” said Crump.

“But one thing that will undoubtedly continue to be absolutely fundamental is partnering meaningfully with patients,” he added.

In November 2020, Eldridge and Crump launched Atlas, a new specialist consultancy that has a focus on supporting clients to connect with patients.

The new consultancy’s team has experience in health policy and behavioural and implementation science and offers five services – find, align, co-design, chart and advance – to its clients.
Atlas is led by managing director Aaron Pond, who previously worked alongside Eldridge and Crump for over a decade. The team comprises specialists with expertise in strategy, change implementation, compliance, patient engagement, social science, co-design and innovation.

“Aaron [Pond] returning to the fold is a testament to the agency’s skill at discovering new talent and the loyalty engendered by team members, past and present. Of all that we have achieved, I am most proud of creating our brilliant team, with all of us uniting with our clients to really understand patients and never settle for ‘that’ll do’,” added Eldridge.